Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AACR 2012 /
Targeted therapy for refractory Ewing’s Sarcoma tumours

31st Mar - 4th Apr 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 13.04.12
Views: 4781
Rating:

Dr Aung Naing -University of Texas MD Anderson Cancer Center, Houston, USA

Dr Naing presents data at a press conference on a combination of targeted therapies that may be effective against relapsed or recurrent Ewing’s sarcoma or desmoplastic small-round-cell tumours.  The results come from a phase I trial presented at the AACR Annual Meeting 2012.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation